Register for our free email digests:
Division of Pfizer Inc.
Latest From Bioheart Inc.
Aastrom Bioscience's stem cell treatment ixmyelocel-T has improved heart function in a Phase IIa study in patients with heart failure due to dilated cardiomyopathy.
START-UP ’s monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions—in in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical devices.
Cipla has made an indirect foray into the stem cell therapy segment through an alliance with Stempeutics Research, a leading Indian stem cell company.
- Specialty Pharmaceuticals
- Therapeutic Areas
- Metabolic Disorders
- Neurology, Nervous System
- AL Labs
- AL Pharma Inc.
- Alpharma Inc.
- North America
- Parent & Subsidiaries
- Pfizer Inc.
- Senior Management
Jeffrey S Campbell, EVP & CFO
Stafan Aigner, EVP, Corp. & Bus. Dev.
Ronald N Warner, PhD, EVP, CSO
- Contact Info
Phone: (908) 566-3800
440 Route 22 E.
P.O. Box 1399 Bridgewater, NJ 08807
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.